Kevin Li

PGY-1 @UCSFUrology | Alum @UCSFMedicine + @UCLA

[Kevin Li @kevndli]

@dr_coops @ShaneNeibart @ben_breyer @hirenpMD @DrSpratticus @TylerSbrt @ShaneNeibart @dr_coops

[Kevin Li @kevndli]

Excited to share our latest work, now out in European Urology!

We followed >166k prostate cancer survivors (1999–2019) using SEER-Medicare. RP+EBRT had the highest risk of urinary adverse events. EBRT surpassed RP at 10 yrs (with BT) & 14 yrs (alone).

https://t.co/GyqW2GmAWl

[Kevin Li @kevndli]

@ShaneNeibart @ben_breyer @dr_coops @hirenpMD Thanks! We followed Jarosek et al. (PMID: 25217421), requiring matching diagnosis and procedure codes on the same claim.

Re: your second question- ongoing work. Early signals more severe events with radiation, but defining severity objectively is hard. More soon!

[Kevin Li @kevndli]

Years of work and support went into this study. Grateful to my mentors @ben_breyer @dr_coops @pcarroll_ and incredible co-authors. Special thanks to Marvin Carlisle and Stephanie Jarosek - couldn’t have done this without you!!

[Kevin Li @kevndli]

Grateful to continue learning from my mentors & role models and to be part of this incredible team @UCSFUrology. Let’s go!!

[Lindsay Hampson @lindsayahampson]

Thrilled to announce our urology match - welcome to the @UCSFUrology family to #RebeccaArteaga, @MeeraGanesh9, #KevinLi, and @danielaoro1471 !!!

@AmerUrological #UroMatch25 @SWIUorg
@ben_breyer @mvankuikenmd

[Matt Cooperberg @dr_coops]

Nice SEER-Medicare study from Kevin Li and @ben_breyer lab @UCSFUrology. Bottom line is the RT footprint does expand over the very long term, and we need to track QOL and toxicity for YEARS after #prostatecancer treatment #wsaua24

[UCSF Health @UCSFHospitals]

E-bike injuries doubled every year from 2017-2022, a UCSF study finds. “There’s probably a lot more public education & enforcement of regulations that can happen, particularly w/ helmets and speed limits," UCSF’s Kevin Li (@kevndli) tells @abc7newsbayarea. https://t.co/1n0lhD7KCE

[Kevin Li @kevndli]

Unique and fun experience working on this paper—now out in @jmirpub! We used ChatGPT to perform qualitative analysis and compared results with humans. Man vs. Machine - is AI the future of qual analysis?@ben_breyer @hirenpMD @RSchwartzPhD @gregamend_md

https://t.co/Yyl39CA4k1

[Kevin Li @kevndli]

Our latest work out in @JUrology - we (@hirenpMD @ben_breyer et al. from @researchTURNS) show that social deprivation index at the zip code level is independently associated with stricture recurrence post-urethroplasty. Link: https://t.co/dV3xIrvEcw #SDOH #urology @UCSFUrology

[UCSF Health @UCSFHospitals]

Since 2017, injuries from e-bikes & scooters have soared, a study in @JAMANetworkOpen finds. “Helmet usage is noticeably lower among electric vehicle users, and risky behaviors, such as riding under the influence, are more prevalent,” UCSF’s Kevin Li says. https://t.co/AMvamYTZIT

[Kevin Li @kevndli]

Our latest research on ebikes/escooters from @ben_breyer lab: https://t.co/ULLxTBESuG
- E-vehicle injuries growing ~exponentially.
- Riskier behavior (less helmets/more alcohol use) in electric vs. conventional vehicle injuries.
- Lower odds of hospital admission in Black riders.

[WashU Medicine Division of Urology @WashU_Uro]

Charlie Jones, MD, joined @UCSFUrology and @UCSF_Epibiostat researchers to evaluate patient perceptions of Medicare reimbursement for artificial urinary sphincter (AUS) placement for @JUrology's Urology Practice: https://t.co/9eYjg8WImn

[Kevin Li @kevndli]

@ec0anarch0 Great observation - e-bikes can also impact pedestrians and other cyclists. We didn’t cover this aspect, but the data are publicly available and include brief narrative descriptions. You can explore here: https://t.co/23TYDmrUVx

[Kevin Li @kevndli]

Happy to share our research on e-bike injuries and hospitalizations published in @JAMASurgery. Thanks to @ben_breyer @DataCooker @hirenpMD for your mentorship and Adrian for partnering!
https://t.co/yFEoPm1eXj

[Umar Ghaffar @UmarGhaffarMD]

Proud to present our latest work about the fragility index in clinical trials relevant to overactive bladder drugs. An interesting index that quantifies the vulnerability of clinical trials. Kudos @kevndli for leading this effort and ofcourse @ben_breyer for mentorship! @UCSFUrology

[Kevin Li @kevndli]

@DrJohnVanSavage @UCSFUrology Not in our case report, but some of the papers we reviewed reported robotic approaches (PMID: 36808427, 34987764, 30093358)!

[Kevin Li @kevndli]

Starting off research year with a poster at #WSAUA23; more to come! @UCSFUrology

[Kevin Li @kevndli]

Proud to share our findings on use of @Cxbladder Monitor during the #COVID19 pandemic to allow bladder cancer patients to skip in-person surveillance cystoscopy w/ negative test. Huge thanks to mentors @SimaPorten @CChuMD et al. for the support and guidance!

[Urologic Oncology @UrolOncol]

Cxbladder Monitor testing to reduce cystoscopy frequency in patients with bladder cancer https://t.co/4NMqn5c1F2

[Urology Gold Journal @urogoldjournal]

Legal review by @kevndli et @ben_breyer from @UCSFUrology of circumcision litigation. What factors predict trial verdict?

https://t.co/hf7kF5g4on